Introduction

Anatomy of the Lung

Overview of Asthma

Questions

Research Questions

Links and Citations

About The Site

Research Questions

 

   

Can Over Exposure of an Allergen Lead to Desensitization to the Allergen and a Reduced Risk of Developing Asthma?

What is Currently Know:

In the case of cats, data does suggest that over exposing children between the ages of 12-14 to cats does not lead to sensitization to cat allergens but does lead to increased levels of IgG antibody response.  In contrast, data regarding increased mite allergen exposure does induce a sensitization to the allergen while levels of IgG4 also increase.  As the graph below indicates, sensitization to cat allergen decreased as the concentration of cat allergen increased. 

 

(Platts-Mills, et al. 2001)

Recent studies have also indicated that houses with pet reduce the occurrence of asthma in children.  The data from the cat allergen experiment would seem to support these recent studies.

What is not known:

At this point in time, only data for cat allergen desensitization can be found.  Data has not yet been collected in regards to any of the other prolific allergens found indoors or outdoors.  To make things more uncertain, some scientist state the opposite is true even in the case of cats (Almqvist C. 2005).  To say the least, among the scientific community this is still a controversial subject.

How can this question be answered?

The same experiment involving cat dander can be used to test whether dog dander produces similar results.  This would help determine whether or not most allergens reduces sensitization at higher concentrations.  After examining the data on the mite allergen, it may also be possible that the concentration of mite allergen was not large enough to illicit the same response as the cat allergen.  A follow up study could also be conducted to reanalyze the dust mite data.

Can asthma or asthma medications hurt the developing fetus during a pregnancy?

What is currently known:

Table. 1— Historical cohort studies examining the effect of maternal asthma on pregnancy outcomes

 

Author yr [ref]
 
Population study yrs
 
Asthma definition
 
Sample size
 
ICS use
 
Poor outcomes associated with asthma
 
Poor outcomes not associated with asthma
 
Gordon et al., 1970 9 USA Actively treated asthma 30861 (all) 277 (asthma) Prior to ICS Perinatal death (severe asthma) Low birth weight
Bahna and Bjerkedal, 1972 10 Norway 1967–1968 Mother's health documented by midwife or physician in birth registry 112530 (control) 381 (asthma) Prior to ICS Pre-term delivery, low birth weight, hyperemesis, haemorrhage, toxemia, induced/complicated labour, neonatal mortality  
Lao and Huengsburg, 1990 11 Hong Kong 1984–1987 History of asthma 87 (control) 87 (asthma) 11% used beclomethasone Low birth weight (mothers not receiving treatment for asthma), C-section (mothers using bronchodilators)  
Perlow et al., 1992 12 USA 1985–1990 Asthma diagnosis reported in perinatal database 130 (control) 81 (asthma) Unclear C-section for foetal distress, pre-term labour and delivery, pre-term premature rupture of membranes, gestational diabetes (steroid-dependent asthma), low birth weight (steroid-dependent asthma) Pre-eclampsia, chronic hypertension, congenital malformations, IUGR
Lehrer et al., 1993 13 USA 1987–1991 Asthma history or asthma requiring treatment 22680 (control) 1435 (asthma history), 136 (asthma with treatment) 136 used ICS Pregnancy-induced hypertension  
Demissie et al., 1998 14 USA 1989–1992 Asthma diagnosis recorded in database 9156 (control) 2289 (asthma) Unknown Pregnancy-induced hypertension, pre-eclampsia, low birth weight, pre-term delivery, congenital malformations Post-partum haemorrhage
Alexander et al., 1998 1 Canada 1991–1993 Completed on prenatal records or maternal admission forms 13709 (control) 817 (asthma) Unclear Antepartum and post-partum haemorrhage C-section, gestational diabetes, pre-term delivery, pregnancy-induced hypertension
Kallen et al., 2000 15 Sweden 1984–1995 Recorded by midwife 36985 (all pregnant females) 15512 (asthma) Unknown Pre-term delivery, low birth weight, post-term birth, infant death Congenital malformations
Wen et al., 2001 16 Canada 1989–1996 Diagnosis recorded in database 34688 (control) 8672 (asthma) Unknown Pre-term labour, pre-eclampsia, pregnancy-induced hypertension, antepartum and post-partum haemorrhage, premature rupture of membranes, C-section Foetal death
Liu et al., 2001 17 Canada 1991–1996 Diagnosis recorded in database 8772 (control) 2193 (asthma) Unknown Small for gestational age, pregnancy-induced hypertension, chorioamnionitis, pre-eclampsia, pre-term delivery Congenital malformations
Olesen et al., 2001 18 Denmark 1991–1996 Primiparae females with diagnosis of asthma and purchase of prescription drugs for asthma 8717 (control) 303 (asthma) 22.5% used ICS Small for gestational age (theophylline users), reduced birth weight and length (mothers who reduced intensity of drug treatment during pregnancy) Congenital malformations
Norjavaara and de Verdier, 2003 19 Sweden 1995–1998 Self-report 293948 (all) 2968 (asthma) All used budesonide C-section Still birth, congenital malformations, reduced birth weight, reduced gestational length

ICS: inhaled corticosteroid; C-section: caesarean section; IUGR: intrauterine growth restriction        http://erj.ersjournals.com/cgi/content/full/25/4/731

The many studies comparing mothers with asthma and mothers without asthma shows that asthmatic mothers are more at risk of giving birth before the due date or giving birth to low weight neonates.  

What is not known:

The mechanisms leading the complications during the pregnancy and birth.  Why asthmatic female are more likely to give birth to low weight neonates.

How can this question be answered?

The difficulty of answering this question involves developing an experimental method that would allow researchers the ability to analyze the differences between asthmatic females during pregnancy so that both the female and fetus is not harmed.  Experiments monitoring the oxygen levels in the blood of females may help answers some questions.  Murine experiments involving asthmatic females may be the best way to explore the effects of maternal asthma on embryonic development.  The effects of asthma medications on embryonic development could also be examined using mice too.  Giving female mice asthma medication during a pregnancy then examining the fetuses for any abnormal development could elucidate the mechanisms behind the changes in a pregnancy as a result of asthma.